blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2675449

EP2675449 - PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA [Right-click to bookmark this link]
Former [2013/52]PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA
[2018/40]
StatusNo opposition filed within time limit
Status updated on  28.02.2020
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  22.03.2019
FormerGrant of patent is intended
Status updated on  14.10.2018
FormerExamination is in progress
Status updated on  10.01.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Aclaris Therapeutics, Inc.
640 Lee Road
Suite 200
Wayne, Pennsylvania 19087 / US
[2019/14]
Former [2013/52]For all designated states
Allergan, Inc.
2525 Dupont Drive
Irvine, California 92886 / US
Inventor(s)01 / SHANLER, Stuart, D.
53 Underhill Drive
Pomona, New York 10970 / US
02 / POWALA, Christopher
714 Woodcrest Road
Radnor, Pennsylvania 19087 / US
 [2013/52]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2019/17]
Former [2013/52]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date12705755.214.02.2012
[2019/17]
WO2012US25068
Priority number, dateUS201161443210P15.02.2011         Original published format: US 201161443210 P
[2013/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012112566
Date:23.08.2012
Language:EN
[2012/34]
Type: A1 Application with search report 
No.:EP2675449
Date:25.12.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 23.08.2012 takes the place of the publication of the European patent application.
[2013/52]
Type: B1 Patent specification 
No.:EP2675449
Date:24.04.2019
Language:EN
[2019/17]
Search report(s)International search report - published on:EP23.08.2012
ClassificationIPC:A61K31/4174, A61K9/00, A61P17/00
[2013/52]
CPC:
A61K9/0014 (EP,CN,KR,RU,US); A61K31/4174 (CN,KR,RU); A61K31/4164 (EP,RU,US);
A61K45/06 (KR,RU,US); A61K47/14 (EP,RU,US); A61K9/06 (EP,CN,KR,RU,US);
A61P17/00 (EP,KR); A61P29/00 (EP); A61P9/00 (EP,KR);
A61P9/14 (EP); A61K2121/00 (RU) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/52]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:OXYMETAZOLINE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNG ZUR BEHANDLUNG VON SYMPTOMEN VON ROSACEA[2018/40]
English:PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA[2018/40]
French:COMPOSITION PHARMACEUTIQUE CONTENTANT DE L' OXYMETAZOLINE POUR LE TRAITEMENT DES SYMPTOMES DE LA ROSACÉE[2018/42]
Former [2013/52]PHARMAZEUTISCHE CREMEZUSAMMENSETZUNGEN AUS OXYMETAZOLIN ZUR BEHANDLUNG VON ROSACEA-SYMPTOMEN
Former [2013/52]PHARMACEUTICAL CREAM COMPOSITIONS OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA
Former [2013/52]COMPOSITIONS DE CRÈME PHARMACEUTIQUE À BASE D'OXYMÉTAZOLINE POUR LE TRAITEMENT DES SYMPTÔMES DE L'ACNÉ ROSACÉE
Entry into regional phase04.09.2013National basic fee paid 
04.09.2013Designation fee(s) paid 
04.09.2013Examination fee paid 
Examination procedure17.12.2012Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.09.2013Examination requested  [2013/52]
03.04.2014Amendment by applicant (claims and/or description)
16.06.2014Despatch of a communication from the examining division (Time limit: M06)
22.12.2014Reply to a communication from the examining division
08.09.2016Despatch of a communication from the examining division (Time limit: M06)
27.02.2017Reply to a communication from the examining division
28.08.2018Cancellation of oral proceeding that was planned for 27.09.2018
27.09.2018Date of oral proceedings (cancelled)
15.10.2018Communication of intention to grant the patent
25.02.2019Fee for grant paid
25.02.2019Fee for publishing/printing paid
25.02.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19170085.5  / EP3578178
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.06.2014
Opposition(s)27.01.2020No opposition filed within time limit [2020/14]
Fees paidRenewal fee
27.02.2014Renewal fee patent year 03
26.02.2015Renewal fee patent year 04
26.02.2016Renewal fee patent year 05
27.02.2017Renewal fee patent year 06
27.02.2018Renewal fee patent year 07
27.02.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.02.2012
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MK24.04.2019
MT24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
[2022/32]
Former [2022/27]HU14.02.2012
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MT24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/49]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/26]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/17]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/14]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/11]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/10]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/09]AL24.04.2019
CZ24.04.2019
DK24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/04]AL24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2019/52]AL24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/51]AL24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/50]AL24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
RS24.04.2019
SE24.04.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/49]AL24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/48]FI24.04.2019
LT24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/47]FI24.04.2019
LT24.04.2019
NO24.07.2019
Cited inInternational search[X]US2004242588  (DEJOVIN JACK [US], et al);
 [X]US2005165079  (SHANLER STUART D [US], et al);
ExaminationWO2005115395
 WO2006105450
 WO2012075319
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.